carvedilol has been researched along with Coronary Stenosis in 7 studies
Coronary Stenosis: Narrowing or constriction of a coronary artery.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The purpose of the present case cohort study compared the control group with no carvedilol administered and the other group of patients given carvedilol and determined whether postoperative treatment with carvedilol, a beta-adrenergic blocker, prevents paroxysmal atrial fibrillation after coronary artery bypass grafting (CABG)." | 7.74 | Postoperative treatment with carvedilol, a beta-adrenergic blocker, prevents paroxysmal atrial fibrillation after coronary artery bypass grafting. ( Izumoto, H; Kawazoe, K; Okabayashi, H; Tsuboi, J, 2008) |
| "Although carvedilol attenuates left ventricular (LV) remodeling in coronary occlusion-reperfusion, it is not known whether it attenuates ischemic LV remodeling because of coronary stenosis (CS) or permanent coronary occlusion (CO)." | 7.71 | Different effects of carvedilol, metoprolol, and propranolol on left ventricular remodeling after coronary stenosis or after permanent coronary occlusion in rats. ( Maehara, K; Maruyama, Y; Sakabe, A; Yaoita, H, 2002) |
| " The purpose of the present case cohort study compared the control group with no carvedilol administered and the other group of patients given carvedilol and determined whether postoperative treatment with carvedilol, a beta-adrenergic blocker, prevents paroxysmal atrial fibrillation after coronary artery bypass grafting (CABG)." | 3.74 | Postoperative treatment with carvedilol, a beta-adrenergic blocker, prevents paroxysmal atrial fibrillation after coronary artery bypass grafting. ( Izumoto, H; Kawazoe, K; Okabayashi, H; Tsuboi, J, 2008) |
| "Although carvedilol attenuates left ventricular (LV) remodeling in coronary occlusion-reperfusion, it is not known whether it attenuates ischemic LV remodeling because of coronary stenosis (CS) or permanent coronary occlusion (CO)." | 3.71 | Different effects of carvedilol, metoprolol, and propranolol on left ventricular remodeling after coronary stenosis or after permanent coronary occlusion in rats. ( Maehara, K; Maruyama, Y; Sakabe, A; Yaoita, H, 2002) |
| "Carvedilol treatment restored the IS reduction by postconditioning, possibly via other mechanism(s) of the ERK and Akt pathways." | 1.35 | Attenuation of cardioprotective effect by postconditioning in coronary stenosed rat heart and its restoration by carvedilol. ( Maruyama, Y; Oikawa, M; Watanabe, K; Yaoita, H, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banach, M | 1 |
| Mariscalco, G | 1 |
| Ugurlucan, M | 1 |
| Rysz, J | 1 |
| Oikawa, M | 2 |
| Yaoita, H | 3 |
| Watanabe, K | 2 |
| Maruyama, Y | 3 |
| Tsuda, E | 1 |
| Minami, N | 1 |
| Kobayashi, J | 1 |
| Fukaya, T | 1 |
| Nozaki, H | 1 |
| Noritake, K | 1 |
| Echigo, S | 1 |
| Koepfli, P | 1 |
| Wyss, CA | 1 |
| Namdar, M | 1 |
| Klainguti, M | 1 |
| von Schulthess, GK | 1 |
| Lüscher, TF | 1 |
| Kaufmann, PA | 1 |
| Ogawa, K | 1 |
| Maehara, K | 2 |
| Tsuboi, J | 1 |
| Kawazoe, K | 1 |
| Izumoto, H | 1 |
| Okabayashi, H | 1 |
| Sakabe, A | 1 |
1 trial available for carvedilol and Coronary Stenosis
| Article | Year |
|---|---|
Beta-adrenergic blockade and myocardial perfusion in coronary artery disease: differential effects in stenotic versus remote myocardial segments.
Topics: Adrenergic beta-Antagonists; Ammonia; Carbazoles; Carbon Isotopes; Carvedilol; Coronary Artery Disea | 2004 |
6 other studies available for carvedilol and Coronary Stenosis
| Article | Year |
|---|---|
Letter by Banach et al regarding article, "postoperative treatment with carvedilol, a beta-adrenergic blocker, prevents paroxysmal atrial fibrillation after coronary artery bypass grafting".
Topics: Adrenergic beta-Antagonists; Atrial Fibrillation; Carbazoles; Carvedilol; Coronary Artery Bypass; Co | 2008 |
Attenuation of cardioprotective effect by postconditioning in coronary stenosed rat heart and its restoration by carvedilol.
Topics: Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Coronary Stenosis; Disease Models, Ani | 2008 |
Acute myocardial infarction after Kawasaki disease in an infant: treatment with coronary artery bypass grafting.
Topics: Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Coronary Aneurysm; Coronary Angiography; Corona | 2009 |
Attenuated cardioprotection by ischemic preconditioning in coronary stenosed heart and its restoration by carvedilol.
Topics: Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Coronary Stenosis; Drug Evaluation, Pr | 2006 |
Postoperative treatment with carvedilol, a beta-adrenergic blocker, prevents paroxysmal atrial fibrillation after coronary artery bypass grafting.
Topics: Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Carbazoles; Carvedilol; Case-Control Studies | 2008 |
Different effects of carvedilol, metoprolol, and propranolol on left ventricular remodeling after coronary stenosis or after permanent coronary occlusion in rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Ascorbic Acid; Carbazoles; Cardi | 2002 |